Torrent Pharma appoints ex-Kotak MD Shanti Ekambaram as Independent Director
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has appointed Shanti Ekambaram, former Deputy Managing Director of Kotak Mahindra Bank, as an Additional Independent Director for a 3-year term starting July 30, 2026, subject to shareholder approval. Ekambaram, 63, brings 39 years of financial services experience and currently serves on the boards of Havells India, Kotak Securities, and IIM Bangalore. She is a Chartered Accountant and not related to any existing director.
Strengthens the board with a high-profile independent director from the banking sector. Routine governance action with no immediate financial impact.